IMPROVEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, giving promising progress throughout several health-related and industrial purposes. With its structural similarity to Obviously derived human serum albumin, OsrHSA delivers a safer, additional reputable alternate for therapeutic us